Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Lactose (India) Ltd (LACTOSE) Share Price & Fundamentals

Company Overview

Founded Year

1991

Listed Year

-

Headquarter

Vadodara, Gujarat, India

MD/CEO

-

Website

https://www.lactoseindialimited.com

Company Facts

What we do

Lactose (India) Ltd manufactures and trades pharmaceutical-grade lactose, pharmaceuticals, dairy products, and formulations with state-of-the-art facilities in Gujarat, India.

Founded in

1,991

Market share

Significant supplier of pharmaceutical lactose and contract manufacturer in India with expanding export markets.

Problem solved

Provides import substitutes for pharmaceutical lactose and manufactures value-added pharmaceutical formulations addressing domestic and export market demands.

Top clients or who we serve

Pharmaceutical companies including multinational firms and domestic sectors; serves B2B primarily.

Key management

-

Our journey and innovations

Started in 1991, expanded lactose capacity, added pharmaceutical formulation and liquid orals divisions, formed strategic alliances, and initiated own marketing in 2022.

Where we operate

Primarily India with exports outside India, including strategic alliances internationally.

Top products or what we offer

Pharmaceutical and edible lactose, lactose IP/BP grades, lactulose, pharmaceutical formulations including tablets and liquid orals, dairy whitener, whey products.

Top brands

Lactose monohydrate and Lactulose Concentrate USP/EP are flagship products; contract manufacturing with Kerry Group and Dr Reddy's.

Raw materials needed

Raw milk and dairy derivatives for lactose and dairy products; pharmaceutical ingredients for formulations.

Raw materials supplier

-

Recurring vs cyclical contribution

Revenue is recurring from pharmaceutical manufacturing, contract manufacturing, and dairy product sales.

Our industry position

Well-established manufacturer and contract manufacturer with compliance to international standards and expanding global presence.

Financial highlights

FY 2024-25 revenue Rs.117.85 crore, net profit Rs.5.16 crore; steady growth in revenue with moderate profitability.

Geographical revenue split

Revenue split: approx. 43% India, 57% outside India exports.

Order book

-

Whats driving growth

Expansion in pharmaceutical formulations, strategic alliances, own brand marketing, and export market development.

Our future plans

Focus on capacity expansions for lactose and lactulose products, enhanced pharmaceutical manufacturing, and increased marketing efforts.

Our green promise

Committed to energy conservation, environmental protection, and sustainable development at manufacturing facilities.

Our people and values

Dedicated workforce with emphasis on safety, health, industrial harmony, and ethical business practices.

Key challenges ahead

Maintaining compliance with regulatory changes, competition, and managing supply chain amidst global uncertainties.

Interesting facts

First Indian company to produce import substitute pharmaceutical grade lactose; strategic alliances with global entities.

Risks and strategy

Mitigates risks through risk management policy, internal controls, and diversification across product segments.

Market Footprint

Top Clients

Top Clients

Pharmaceutical companies including multinational firms and domestic sectors; serves B2B primarily.

Top Products

Top Products

Pharmaceutical and edible lactose, lactose IP/BP grades, lactulose, pharmaceutical formulations including tablets and liquid orals, dairy whitener, whey products.

Price Movement & Share Holding

Today's High/Low

102.15116

52 Week High/Low

76.01136.45
Past Returns

1 week

1.86%

1 month

0.56%

3 month

8.19%

1 year

-6.43%

3 year

77.77%

5 year

183.82%

Share Holding

Promoters

53.65%

FII

0%

DII

0%

Retail

39.72%

Others

6.63%

Company Overview

Founded Year

1991

Listed Year

-

Headquarter

Vadodara, Gujarat, India

MD/CEO

-

Website

https://www.lactoseindialimited.com

Price Movement & Share Holding

Today's High/Low

102.15116

52 Week High/Low

76.01136.45

Past Returns

1 week

1.86%

1 month

0.56%

3 month

8.19%

1 year

-6.43%

3 year

77.77%

5 year

183.82%

Share Holding

Promoters

53.65%

FII

0%

DII

0%

Retail

39.72%

Others

6.63%

Company Facts

What we do

Lactose (India) Ltd manufactures and trades pharmaceutical-grade lactose, pharmaceuticals, dairy products, and formulations with state-of-the-art facilities in Gujarat, India.

Founded in

1991

Market share

Significant supplier of pharmaceutical lactose and contract manufacturer in India with expanding export markets.

Problem solved

Provides import substitutes for pharmaceutical lactose and manufactures value-added pharmaceutical formulations addressing domestic and export market demands.

Top clients or who we serve

Pharmaceutical companies including multinational firms and domestic sectors; serves B2B primarily.

Our journey and innovations

Started in 1991, expanded lactose capacity, added pharmaceutical formulation and liquid orals divisions, formed strategic alliances, and initiated own marketing in 2022.

Where we operate

Primarily India with exports outside India, including strategic alliances internationally.

Top products or what we offer

Pharmaceutical and edible lactose, lactose IP/BP grades, lactulose, pharmaceutical formulations including tablets and liquid orals, dairy whitener, whey products.

Top brands

Lactose monohydrate and Lactulose Concentrate USP/EP are flagship products; contract manufacturing with Kerry Group and Dr Reddy's.

Raw materials needed

Raw milk and dairy derivatives for lactose and dairy products; pharmaceutical ingredients for formulations.

Recurring vs cyclical contribution

Revenue is recurring from pharmaceutical manufacturing, contract manufacturing, and dairy product sales.

Our industry position

Well-established manufacturer and contract manufacturer with compliance to international standards and expanding global presence.

Financial highlights

FY 2024-25 revenue Rs.117.85 crore, net profit Rs.5.16 crore; steady growth in revenue with moderate profitability.

Geographical revenue split

Revenue split: approx. 43% India, 57% outside India exports.

Whats driving growth

Expansion in pharmaceutical formulations, strategic alliances, own brand marketing, and export market development.

Our future plans

Focus on capacity expansions for lactose and lactulose products, enhanced pharmaceutical manufacturing, and increased marketing efforts.

Our green promise

Committed to energy conservation, environmental protection, and sustainable development at manufacturing facilities.

Our people and values

Dedicated workforce with emphasis on safety, health, industrial harmony, and ethical business practices.

Key challenges ahead

Maintaining compliance with regulatory changes, competition, and managing supply chain amidst global uncertainties.

Interesting facts

First Indian company to produce import substitute pharmaceutical grade lactose; strategic alliances with global entities.

Risks and strategy

Mitigates risks through risk management policy, internal controls, and diversification across product segments.

Market Footprint

Top Clients

Top Clients

Pharmaceutical companies including multinational firms and domestic sectors; serves B2B primarily.

Top Products

Top Products

Pharmaceutical and edible lactose, lactose IP/BP grades, lactulose, pharmaceutical formulations including tablets and liquid orals, dairy whitener, whey products.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions